InvestorsHub Logo
Followers 2
Posts 2022
Boards Moderated 0
Alias Born 05/11/2017

Re: None

Wednesday, 02/20/2019 10:33:34 AM

Wednesday, February 20, 2019 10:33:34 AM

Post# of 108192
HOT trial on clinicaltrials.gov:

Study of ADXS-503 With or Without Pembro in Subjects With Metastatic Non-Small Cell Lung Cancer
https://clinicaltrials.gov/ct2/show/NCT03847519?term=advaxis&draw=1&rank=2

Pembro (aka Keytruda) is our PD/L1 inhibitor for HOT combo trials.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ADXS News